Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients
Clinical trial NCT02732938 · TERMINATED
Trial details
- NCT number
- NCT02732938
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-04
- Primary completion
- 2017-09-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.